ABC News’ Phil Lipof speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug ...

Kennedy is Trump’s pick for health secretary, but he has a history of spreading misinformation about a range of issues.

Revumenib is now an FDA-approved treatment for adult and pediatric patients with relapsed/refractory KMT2A-rearranged acute ...

Eyenovia said on Friday it will discontinue a late-stage study for its experimental drug-device combination to treat near-sightedness and cut about 50% of its workforce.

As optimism for GLP-1 receptor agonists for weight loss has grown, so too has their use in children. Currently, liraglutide ...

Clinical trials are a significant part of the drug development cycle. However, the process has remained unchanged in recent ...

Eli Lilly contends it should be allowed to vet data from 340B hospitals before providing rebates, rather than offer upfront ...

Any changes Robert F. Kennedy Jr. wants to make will come up against a pharmaceutical industry that pays much of the U.S.

Put up against placebo in the phase 3 EMBARK trial, delandistrogene moxeparvovec (Elevidys) did not significantly improve ...

Experts are unsure as to what is causing the decline, which saw deaths decrease by some 14% between June 2023 and 2024.

The prosecutor also applied that the video evidence from the data extracted from the defendant’s phone be played in open court.

New analysis from the DETECT-A study supports MCED testing as a complement to current guideline-recommended screening in lung ...